Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP618289.RA4bv_feesL9ipaWiTKc_GCsLUchr8F2SnCJj-EuiQS-4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP618289.RA4bv_feesL9ipaWiTKc_GCsLUchr8F2SnCJj-EuiQS-4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP618289.RA4bv_feesL9ipaWiTKc_GCsLUchr8F2SnCJj-EuiQS-4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP618289.RA4bv_feesL9ipaWiTKc_GCsLUchr8F2SnCJj-EuiQS-4130_provenance.
- NP618289.RA4bv_feesL9ipaWiTKc_GCsLUchr8F2SnCJj-EuiQS-4130_assertion description "[We also found that the 3435TT genotype of MDR1 was associated with a lower risk of non-cardiac cancer (OR = 0.42; 95% CI = 0.23-0.79), middle-third cancer (OR = 0.36; 95% CI = 0.17-0.77), advanced cancer (OR = 0.31; 95% CI = 0.13-0.73), venous invasion (OR = 0.30; 95% CI = 0.10-0.91), and lymph node metastasis (OR = 0.28; 95% CI = 0.13-0.65).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618289.RA4bv_feesL9ipaWiTKc_GCsLUchr8F2SnCJj-EuiQS-4130_provenance.
- NP618289.RA4bv_feesL9ipaWiTKc_GCsLUchr8F2SnCJj-EuiQS-4130_assertion evidence source_evidence_literature NP618289.RA4bv_feesL9ipaWiTKc_GCsLUchr8F2SnCJj-EuiQS-4130_provenance.
- NP618289.RA4bv_feesL9ipaWiTKc_GCsLUchr8F2SnCJj-EuiQS-4130_assertion SIO_000772 17608636 NP618289.RA4bv_feesL9ipaWiTKc_GCsLUchr8F2SnCJj-EuiQS-4130_provenance.
- NP618289.RA4bv_feesL9ipaWiTKc_GCsLUchr8F2SnCJj-EuiQS-4130_assertion wasDerivedFrom befree-2016 NP618289.RA4bv_feesL9ipaWiTKc_GCsLUchr8F2SnCJj-EuiQS-4130_provenance.
- NP618289.RA4bv_feesL9ipaWiTKc_GCsLUchr8F2SnCJj-EuiQS-4130_assertion wasGeneratedBy ECO_0000203 NP618289.RA4bv_feesL9ipaWiTKc_GCsLUchr8F2SnCJj-EuiQS-4130_provenance.
- befree-2016 importedOn "2016-02-19" NP618289.RA4bv_feesL9ipaWiTKc_GCsLUchr8F2SnCJj-EuiQS-4130_provenance.